This year, the Superior Court of Justice (STJ) ruled that health plans must only cover treatments that are included in the list of the National Supplementary Health Agency (ANS).
However, Law No. 14,454/2022 was sanctioned, originating from Bill No. 2,033/2022 approved in the Senate at the end of August, which determines that health plans cover the costs of treatments that are outside the exhaustive list listed by the ANS.
According to Law No. 14,454/2022, the cost of treatment must be covered by the health plan if (i) it has scientifically proven efficacy; (ii) it is recommended by the National Commission for the Incorporation of Technologies into the SUS; or (iii) it is recommended by a health technology assessment body with high international renown.
